Great-West Life introduces the SMART drug plan In June 2017, Great-West Life is introducing the SMART drug plan, aiming for Sustainable, Managed and Reasonable Treatment. Like Manulife’s DrugWatch, SMART will bring more rigourous review to selected new drugs and indications and likely delay product entry into its formularies. Great-West Life indicates its reviews will not only rely on the Canadian Agency for Drugs and Technology in Health (CADTH). As…